These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 558637)

  • 61. Identification of the major urinary metabolite of thromboxane B2 in the monkey.
    Roberts LJ; Sweetman BJ; Morgan JL; Payne NA; Oates JA
    Prostaglandins; 1977 Apr; 13(4):631-47. PubMed ID: 404671
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Thromboxane A2 and prostaglandin H2: potent stimulators of the swine coronary artery.
    Svensson J; Hamberg M
    Prostaglandins; 1976 Dec; 12(6):943-50. PubMed ID: 1005743
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
    Lewis GP; Watts IS
    Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Selective inhibition of thromboxane A2 biosynthesis in blood platelets.
    Gryglewski RJ; Zmuda A; Korbut R; Krecioch E; Bieron K
    Nature; 1977 Jun; 267(5612):627-8. PubMed ID: 406572
    [No Abstract]   [Full Text] [Related]  

  • 65. The effects of dipyridamole on TXA2 formation by horse platelet microsomes.
    Katano Y; Imai S
    Prostaglandins Leukot Med; 1983 Feb; 10(2):179-85. PubMed ID: 6573686
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thromboxane synthetase inhibition as antithrombotic strategy.
    Vermylen J; Defreyn G; Carreras LO; Machin SJ; Van Schaeren J; Verstraete M
    Lancet; 1981 May; 1(8229):1073-5. PubMed ID: 6112447
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Increased thromboxane B2 biosynthesis in platelets.
    Kawaguchi H; Ishibashi T; Imai Y
    Lipids; 1982 Sep; 17(9):577-84. PubMed ID: 6815401
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CGS 12970: a novel, long acting thromboxane synthetase inhibitor.
    Ambler J; Butler KD; Ku EC; Maguire ED; Smith JR; Wallis RB
    Br J Pharmacol; 1985 Oct; 86(2):497-504. PubMed ID: 2932197
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Studies on the thromboxane synthesizing system in human platelet microsomes.
    Tai HH; Yuan B
    Biochim Biophys Acta; 1978 Dec; 531(3):286-94. PubMed ID: 737191
    [TBL] [Abstract][Full Text] [Related]  

  • 70. UK-37, 248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity.
    Randall MJ; Parry MJ; Hawkeswood E; Cross PE; Dickinson RP
    Thromb Res; 1981 Jul 1-15; 23(1-2):145-62. PubMed ID: 6795753
    [No Abstract]   [Full Text] [Related]  

  • 71. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
    Vezza R; Mezzasoma AM; Venditti G; Gresele P
    Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Action of selective inhibitor of thromboxane synthetase on experimental thrombosis induced by arachidonic acid in rabbits.
    Puig-Parellada P; Planas JM
    Lancet; 1977 Jul; 2(8027):40. PubMed ID: 69127
    [No Abstract]   [Full Text] [Related]  

  • 73. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Thromboxane formation from arachidonic acid and prostaglandin H2 in rabbit spleen.
    Hidaka T; Ueta T; Ogura R
    J Biochem; 1983 Feb; 93(2):367-73. PubMed ID: 6404897
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of SQ 80,338 (1-(3-phenyl-2-propenyl)-1H-imidazole) on thromboxane synthetase activity and arachidonic acid-induced platelet aggregation and bronchoconstriction.
    Harris DN; Greenberg R; Phillips MB; Osman GH; Antonaccio MJ
    Adv Prostaglandin Thromboxane Res; 1980; 6():437-41. PubMed ID: 7189949
    [No Abstract]   [Full Text] [Related]  

  • 76. Formation by phospholipase A2 of prostaglandins and thromboxane A2-like activity in the platelets of normal and essential fatty acid deficient rats. Comparison with effect on human and rabbit platelets.
    Vincent JE; Zijlstra FJ
    Prostaglandins; 1977; 14(6):1043-53. PubMed ID: 601247
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evidence for a bidirectional prostaglandin endoperoxide shunt between platelets and the bovine coronary artery.
    Mayeux PR; Kadowitz PJ; McNamara DB
    Biochim Biophys Acta; 1989 Mar; 1011(1):18-24. PubMed ID: 2493809
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Platelet and blood vessel arachidonate metabolism and interactions.
    Needleman P; Wyche A; Raz A
    J Clin Invest; 1979 Feb; 63(2):345-9. PubMed ID: 372240
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Biosynthesis of thromboxanes.
    Hammarström S; Diczfalusy U
    Adv Prostaglandin Thromboxane Res; 1980; 6():267-74. PubMed ID: 6770598
    [No Abstract]   [Full Text] [Related]  

  • 80. Prostaglandin endoperoxides promote calcium release from a platelet membrane fraction in vitro.
    Gerrard JM; Butler AM; Graff G; Stoddard SF; White JG
    Prostaglandins Med; 1978 Nov; 1(5):373-85. PubMed ID: 364508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.